MEK/ERK pathway, one of three subgroups within MAPK pathways, is reported that involved in the tumorigenesis of numerous cancers by facilitating tumor growth, metastasis, angiogenesis, and extracellular matrix degradation [41]. This evidence concerns the gene MAP2K7 and neoplasm.